Carotid body chemoreceptor

The **carotid body chemoreceptor** refers to a small cluster of neuroendocrine cells (primarily type I or glomus cells, supported by type II or sustentacular cells) located at the bifurcation of the common carotid artery[1][3][5]. These cells continuously monitor arterial blood for decreases in oxygen (hypoxia), increases in carbon dioxide (hypercapnia), and reduced pH (acidosis), triggering reflex changes in respiration and sympathetic nervous system output to maintain homeostasis[1][3][5][6][7]. Rather than being a single protein or receptor, the carotid body chemoreceptor is an organ-level functional unit composed of multiple interacting cell types, neurotransmitters (such as acetylcholine, ATP, dopamine), and synaptic connections with sensory afferents from the glossopharyngeal nerve (carotid sinus nerve), projecting to the brainstem[3][5][6]. It plays a crucial role in acute adaptation to hypoxemia but is not considered a druggable molecular target like a classical receptor, transporter, or enzyme. — **Note**: - The "carotid body chemoreceptor" is not a single molecule, protein, or classical drug target, but an organ-level chemosensory system. Queries for a specific drug target should identify individual molecular components within the carotid body (e.g., ion channels, enzymes, or neurotransmitter receptors), not the whole organ or cluster. - Is_incorrect is marked "true" because "carotid body chemoreceptor" does not conform to the standard definition of a drug target (single molecule or protein) but to an anatomical/functional cluster[1][3][5][6][7].

Other names

Carotid bodyCarotid glomusGlomus caroticum

Modulation of carotid body activity (e.g., through neural or surgical intervention, rather than direct molecular drug targeting)